In Brief
Monocytes are circulating, short-lived blood cells. Here, Mildner et al. (2017) use transcriptome and epigenome profiling to study murine monocyte identities and subset interrelations. They highlight the critical role of C/EBPb in monocyte conversion and reveal that while Ly6C + and Ly6C
À monocytes are homogeneous in steady state, Ly6C int cells display heterogeneity. Mildner et al., 2017, Immunity 46, 849- (Ginhoux and Jung, 2014) . Adult steady-state monopoiesis occurs in bone marrow (BM), where monocytes arise in a developmental sequence from dedicated precursor cells. Specifically, monocyte-macrophage DC progenitors (MDP) (Fogg et al., 2006) give rise to common monocyte progenitors (cMoP) committed to monocyte generation (Hettinger et al., 2013) . Two main CD14 + CD16 À and CD14 int CD16 + monocyte populations have been identified in human blood (Passlick et al., 1989 (Geissmann et al., 2003; Palframan et al., 2001; Sunderkö tter et al., 2004) . Ly6C + monocytes arise in the BM, where they represent the majority of monocytes ($90%). Once in the blood, Ly6C
+ monocytes are characterized by a high degree of developmental plasticity. Specifically, these cells sense injury and extravasate into tissues, where their descendants have emerged as a highly plastic cellular system that complements the classical tissue-resident mononuclear phagocyte populations, i.e., macrophages and DC . Also during homeostasis, Ly6C + monocytes contribute to macrophage compartments of selected tissues (Varol et al., 2007; Molawi et al., 2014; Bain et al., 2016; Kim et al., 2016) . The latter is likely related to environmental or physiological challenges of these organs and can vary among genders and mouse strains. Ly6C À monocytes are considered to remain in the vasculature. A fraction of these cells patrols the vessel walls, acting as scavengers and orchestrating tissue repair (Auffray et al., 2007; Carlin et al., 2013) . Circulating Ly6C + monocytes give rise to Ly6C À monocytes, as
shown for mice and primates by sequential BrdU incorporation of the subset (Sugimoto et al., 2015; Yona et al., 2013) , re-population kinetics following depletion regimes (Sunderkö tter et al., 2004) , and direct adoptive transfer of Ly6C + monocytes (Varol et al., 2007; Yona et al., 2013) . Furthermore, following monocyte precursor engraftment, Ly6C À cells arise with delay compared to Ly6C + monocytes (Varol et al., 2007; Hettinger et al., 2013) . Development of both blood monocyte subsets depends on the ''pioneer'' or lineage determining transcription factor PU.1 (encoded by Spi1; Scott et al., 1994) . Mutations of Ccr2 (Serbina and Pamer, 2006) , Irf8 (Kurotaki et al., 2013) , and Klf4 (Alder et al., 2008; Feinberg et al., 2007) preferentially affect Ly6C + monocytes, while Nr4a1 (Nur77) deficiency affects Ly6C À monocytes (Hanna et al., 2011) . However, fate-mapping experiments have shown that absence of Ly6C + monocytes can trigger a compensatory half-life extension of Ly6C À cells, and thereby mask the impairment of the Ly6C À compartment in mutants . Thus, deficiencies, including Irf8, Klf4, and CCR2, generally affect both monocyte subsets (Alder et al., 2008; Kurotaki et al., 2013; Yona et al., 2013) . Likewise, also Nr4a1-deficient Ly6C + monocytes fail to compete with their wild-type counterpart in mixed BM chimeric mice (Hanna et al., 2011) .
Here we have systematically characterized the murine circulating monocyte subsets, including population-level and massively parallel single cell RNA sequencing (MARS-seq; Jaitin et al., 2014) , a global analysis of accessible chromatin regions (ATAC-seq) and indexed chromatin immunoprecipitation (iChIP) to define epigenetic landscapes. We show that steady-state differentiation of Ly6C + monocytes into Ly6C À cells ensued rapid transcriptomic changes accompanied by prevalent de novo gain of enhancer activity with only minor promoter changes. Including data from grafted Ly6C + monocytes, our results support and extend previous reports showing developmental progression from Ly6C + monocytes to Ly6C À cells. Mechanistically, we identified the induction of CCAAT-enhancer-binding protein beta (C/EBPb) as part of the Ly6C À differentiation program, activating the monocyte survival factor Nr4a1, and show that C/EBPb-deficiency impaired the generation of circulating Ly6C À monocytes.
RESULTS

Molecular Characterization of Murine Monocytes and Their Progenitors
To map molecular determinants guiding monocyte development ( Figure 1A ), we isolated MDP, cMoP, BM Ly6C + and Ly6C À monocytes, as well as the three phenotypically distinct Ly6C + , Ly6C int , and Ly6C À blood monocyte populations from adult C57BL/6 mice ( Figure 1B ) and performed transcriptome analysis.
Comparative analysis of the populations revealed disparate regulation of 6,064 genes (>2-fold differences in any pairwise comparison among a total of 15,733 genes; Figures 1C and 1D and Figure S1A ). A cluster defined by MDP (cluster I) was characterized by genes associated with a progenitor phenotype, including Hoxa7, Cd34, and Flt3 (Figures 1C and 1D) . Cluster II comprised genes co-expressed by MDP and cMoP, including Kit, S1pr3, Myc, and Myb ( Figures 1C and 1D) . Genes, such as Cdk2, Cdk4, and members of the Mcm gene family, indicated overrepresentation of the cell-cycle pathway (p = 3.5e -18 , Figure S1B ). An even stronger enrichment of cell-cycle genes was found in cluster III (p = 1.6e -57 , Figure S1B ) defined by high expression in cMoP and BM Ly6C + monocytes, indicating that at least a fraction of BM Ly6C + monocytes retained proliferative capacity, as reported earlier (Hettinger et al., 2013 Figure 1D ). Similar results were obtained with an independent dataset, even though some differences between the experiments were evident, indicating the sensitivity of monocytes toward small environmental differences ( Figure S2 ). The substantial expression changes between Ly6C + and Ly6C À monocytes suggested that linear progression of these cells (Sunderkö tter et al., 2004; Varol et al., 2007; Yona et al., 2013) was driven by transcriptomic changes. Transferred Ly6C + monocytes isolated from BM or spleen lose Ly6C expression and gain CX 3 CR1, rendering them phenotypically indistinguishable from Ly6C À monocytes (Varol et al., 2007; Yona et al., 2013) ; however, the molecular relationship of grafted monocytes and their derivatives to host monocyte populations had not been investigated.
To probe whether converted monocytes reflected the molecular changes seen in endogenous Ly6C
À monocytes, we isolated CD117 À CD11b + CD115 + Ly6C + BM monocytes from CD45.1 congenic mice and transferred them into the bloodstream of CD45.2 WT animals ( Figure 2A ). Cells were retrieved from recipient blood 24 hr, 36 hr, and 48 hr after transfer, sorted based on their CD45.1, CD11b, and CD115 expression and subjected to comprehensive transcriptional analysis (n = 2 per time point, Figure 2B ). During this time, transferred monocytes gradually lost the Ly6C surface marker ( Figure 2B ). Host Ly6C and Ly6C À by RNA-Seq. Analysis was restricted to genes, which showed a 2-fold difference in at least one cell population and sample. K-means clustering was set to n = 6. See also related Figure S1 for GO-enrichment and TF expression in monocyte subsets. 3-4 mice were used for this experiment. Similar results of an independent experiment can be found in Figure S2 .
(D) Examples of gene expression from the six identified clusters depicted in (C). Shown are the mean sequence reads ± STD.
Ly6C int
, and Ly6C À blood monocyte populations were isolated alongside to control for potential injection-related side effects. In parallel, graft-derived cells were also retrieved from recipient spleens ( Figure S3 ). Transcriptional profiling of monocyte samples revealed many genes to be differentially regulated in any pairwise comparison (1,677 genes, Figure 2C , Figure S4A ). We identified a cluster of genes specific for the Ly6C + BM monocyte graft (cluster I) ( Figures 2C and 2D) Figure 2E ). Global correlation of gene expression of the transferred cells versus Ly6C + host cells was only moderate (r = 0.51), while the correlation to Ly6C int (r = 0.81) and Ly6C À (r = 0.85) host monocytes was higher ( Figure 2E ), demonstrating their conversion. In contrast, the earlier 24 hr time point showed a higher correlation toward the Ly6C int than Ly6C À monocyte phenotype (r = 0.79 versus r = 0.69; Figure S4B Figure S5C ).
Focusing on gene expression, we could relate the gene program of Ly6C + monocytes Ccr2, Ly6c2, Mpeg1, Sell, and Irf8) to cluster I cells ( Figure 3C , Figure S5D ). Monocytes within cluster II, characterized by intermediate surface display of Ly6C and CD62L, showed specific expression of MHCII-related genes (Cd74, H2-aa, Ciita) and expressed Ccr2, as well as Cd209a ( Figure S5E ). While our data closely link these cells to the Ly6C int subset, they might be related to a recently reported monocyte subset biased to generate DC-like cells (Menezes et al., 2016) . Surface MHCII expression by 50% of the Ly6C int monocytes was further validated by flow cytometry analysis ( Figure S5F ). Cluster III monocytes did not display a RNA-seq. Samples were analyzed in duplicates and analysis was restricted to genes, which showed a 2-fold difference in at least one cell population and sample. K-means clustering was set to n = 8. Respective GO-enrichment can be found in Figure S4A .
(D) Examples of expression levels from individual genes identified by the cluster analysis depicted in (C). Shown are the mean sequence reads ± STD.
(E) Correlation analysis of the expression signature of monocytes isolated 48 hr after transfer against host Ly6C + , Ly6C int , and Ly6C À monocyte subsets. The 1,471 differential expressed genes without the BM-specific cluster I shown in (C) were included (cluster II-VIII) and the average of the duplicates were used for calculation. Sequence reads are presented as log 2 values. See also related Figure S4B . Figure 3C ). To illustrate developmental relationship between the monocytes, we next used diffusion maps to project each single cell to a location in two-dimensional space . All four clusters were separated territorially in the projected map ( Figures 3D and 3E ). To further visualize expression patterns across the single cell data, we overlaid gene expression on the dimensionality reduction space. Sell and Ly6c2 were found restricted to Ly6C + monocytes in cluster I, while Lyz2 and Ccr2 expression was also shared by cluster II cells ( Figure 3F ). Cluster II also specifically expressed Cd209a, MHCII-related genes, such as H2-aa, while Cd36 was absent. Cluster III represented an intermediate subset that linked cluster I with cluster IV, i.e., Ly6C + and Ly6C À monocytes, characterized by induction of
Itgal, Cebpb, and Cd36 expression. Expression of these genes peaked in cluster IV, and was accompanied by Nr4a1 expression ( Figure 3F ). , 2014) and performed an chromatin accessibility assay (transposase-accessible chromatin; ATAC-seq) (Buenrostro et al., 2013) . Histone modifications inform on the activity state of cis-acting genomic regulatory elements. Specifically, promoters are identified according to proximity to transcription start sites (TSS) and tri-methylation of lysine 4 on the histone H3 N-terminal tail (H3K4me3), while enhancers are defined by their distance from the TSS (> 1 kb) and enrichment of H3K4me1 and H3K4me2 marks (Heintzman et al., 2007) . Enhancers can be further classified into ''poised'' (H3K4me1 + ) and active (H3K4me1 + , H3K27ac + ) (Creyghton et al., 2010) .
Analysis of total H3K4me3 peaks (peak center < 1 kb from TSS) in the main monocyte subsets identified 9,635 promoters, 35 of which were differently used between Ly6C + and Ly6C À monocytes ( Figure 4A ). This represents 0.36% differentially regulated H3K4me3 marks, whereas transcriptional changes among the monocytes reached 8.4% ( Figure 4B Figure 4A and Figure S6B ), corroborating that Ly6C + to Ly6C À monocyte conversion involves de novo enhancer generation, rather than enhancer decommission, i.e., me1 and me2 de-methylation. Finally, prominent changes were evident in histone acetylation, with 77 regions (60 genes) displaying reduced H3K27ac (E) Analysis of all 40,572 detected ATAC peaks, from which 423 peaks showed an at least 50% higher read count in Ly6C + monocytes (dark red) and 886 peaks were enriched in Ly6C À monocytes (orange). Examples of IGV tracks can be found in Figure S6C .
(legend continued on next page) modification and 563 regions (313 genes) gaining acetylation during monocyte differentiation. This was consistent with the high number of de novo enhancers generated during the conversion. Importantly, Ly6C int monocytes were characterized by an overlapping phenotype and shared histone modification patterns with Ly6C + as well as Ly6C À monocytes, but lacked unique regulatory elements ( Figure 4D ). Collectively, this revealed a specific and prevalent gain of enhancer activity in Ly6C À monocytes with only minor H3K4me3-marked promoter changes.
To define open chromatin regions and identify transcription factor binding motifs enriched for the specific monocyte populations, we applied ATAC-seq (Buenrostro et al., 2013) Figure 4E ). To identify potential transcription factors responsible for transcriptome and epigenome regulation during monocyte conversion, we examined the ATAC data for enrichment for transcription factor binding motifs within the differential accessible regions (Lara-Astiaso et al., 2014; Lavin et al., 2014) . We identified both known and previously unknown candidate regulators, including Spi1 (Pu.1), Fosl2, Cebp, and SpiC motifs enriched in Ly6C + monocytes and Nr4a1, Spi1, Cebp, Runx2, and Klf motifs enriched in Ly6C À monocytes ( Figure 4F ).
We next compared the predicted motif enrichment in monocyte subsets with the transcription factor expression in these cells ( Figure 4G , Figure S6D ). Spi1, Klf2, Klf4, and Nr4a1 were prominently expressed in monocytes and increased with acquisition of the Ly6C À phenotype, confirming the requirement of these transcription factors for monocyte differentiation (Feinberg et al., 2007; Hanna et al., 2011; Scott et al., 1994) . Notably, RNAseq analysis further revealed distinction within certain transcription factor families, such as the one comprising various members of the C/EBP family, which bind similar motifs and are therefore not resolved by chromatin footprint analysis. Within the C/EBP family, Cebpb was the most prominently expressed gene, correlating well with the predicted transcription factor motif analysis. Generally, monocyte conversion was associated with a shift from C/EBPa and d to C/EBPb prevalence ( Figure 4G ).
Ly6C -Monocytes Are Dependent on the Transcription
Factor C/EBPb Monocyte conversion was associated with prominent alterations within the C/EBP transcription factor family ( Figure 4G ). Specifically, upregulation of Cebpb in Ly6C À monocytes compared to Ly6C + cells, as well as after monocyte transfer suggested a role of C/EBPb in late monocyte development ( Figure 1C and Figure 2D ). Indeed, monocytes were reported to be affected in C/EBPb-deficient animals (Tamura et al., 2015) , although it had not been addressed whether the effect was cell-intrinsic or restricted to a specific subset. Analysis of peripheral blood of C/EBPb-deficient mice and littermate controls revealed that Ly6C
+ monocytes were present in comparable frequency in both mouse strains, Ly6C int monocytes showed a 50% reduction but Ly6C À blood monocytes were absent ( Figure 5A ). Also BM Ly6C À monocytes were strongly reduced, while monocytic precursors, such as MDP, cMOP, or BM Ly6C + monocytes were present at similar frequencies in mutants and controls ( Figure 5B ). To investigate whether the monocyte impairment of Cebpb À/À mice resulted from a cell-intrinsic defect, we performed a competitive repopulation assay, in which Cebpb À/À BM was mixed 1:1 with WT littermate BM and transplanted into lethally irradiated WT recipients. Analysis of the resulting chimeras 8 weeks after engraftment revealed that both genotypes contributed equally to MDP and cMoP ( Figure 5C Figure 5C ). These data establish the direct cell-intrinsic requirement of C/EBPb for the generation or survival of Ly6C À monocytes.
Encoded by an intron-less gene, C/EBPb is expressed in distinct isoforms with different biological functions (Smink et al., 2009) . A short, N-terminally truncated protein, the liver-enriched transcriptional inhibitory protein (LIP), lacks the transactivation domain and acts mainly as a dominant-negative C/EBPb isoform (Descombes and Schibler, 1991) . As compared to a C/EBPb WT control (CoKi; C/EBPb cDNA inserted into the cebpb locus) (Wethmar et al., 2010) , expression of the C/EBPb LIP isoform (Bé gay et al., 2015) failed to rescue the developmental defect of Ly6C À monocytes observed in Cebpb À/À mice (Figure 5D ). Moreover, LIP animals displayed a strong reduction in all monocyte subsets ( Figure 5D ). The dominant effect of this physiological C/EBP inhibitor corroborates the importance of C/EBP transcription factor for monocyte differentiation and the requirement for proper C/EBP isoform balance.
To further dissect the impairment of the Ly6C À monocyte compartment by the C/EBPb deficiency, we isolated monocytes of Cebpb À/À mice and control littermates and performed RNA-seq on these samples ( Figure 5E ). Clustering of differentially expressed genes revealed that the ''Ly6C À monocyte gene signature'' was downregulated in C/EBPb-deficient Ly6C int cells indicating a developmental block of the ''Ly6C À gene program''
( Figure 5E ). Respective gene clusters (I, II) included Cebpb, Nr4a1, Bcl2, and Itgal ( Figure 5F ). The ''monocytic Ly6C + gene signature'' including Ly6c2, Lyz2, Sell, and Fos, was present in C/EBPb-deficient Ly6C + monocytes (cluster III, IV) ( Figure 5F ). More related genes can be found in Figure S6D . We also identified genes specifically upregulated in Ly6C + and Ly6C int Cebpb À/À monocytes compared to controls (cluster V, VI). These clusters comprised other members of the C/EBP family, such as Cebpa and Cebpe, suggesting compensation for or loss of repression by C/EBPb. Also genes belonging to the ''MHC gene family,'' such as H2-aa, H2-eb1, and Cd74, were higher expressed in C/EBPb-deficient Ly6C int monocytes (cluster VI, Figure 5F ). Similarly, Cd209a was strongly enriched in these cells, while Cd36 was absent, indicating that the alternative differentiation pathway of Ly6C + monocytes toward Cd209a-expressing Ly6C int cells is probably C/EBPb-independent. Figure 5F ), suggesting that C/EBPb is involved in Nr4a1 regulation. To identify C/EBPb binding sites at the Nr4a1 locus, we examined the C/EBPb binding pattern of cultured monocyte-derived cells (Bornstein et al., 2014) . Two open chromatin regions upstream of the first exon of the Nr4a1 gene were found in all monocyte subsets (À50 bp [blue symbol] and À850 bp [purple symbol] from the TSS). Sequence analysis revealed that all regions harbored C/EBPb binding motifs ( Figure 6A ). In these cells, the À850 bp site was occupied by C/EBPb, whereas the À50 bp site displayed only a weak signal ( Figure 6A) . Notably, this imperfect site had been reported earlier to be involved in C/EBPb-dependent Nr4a1 expression in rat cells (El-Asmar et al., 2009 ). In addition, a À4 kb distal enhancer element was occupied by C/EBPb (white symbol; Figure 6A ). To probe for differential contributions of the elements, we cloned combinations of regulatory regions upstream to a firefly luciferase gene reporter and transfected Cebpb À/À MEF cells with the constructs (Figure 6B) . Following introduction of ectopic C/EBPb, we measured relative luciferase expression normalized to renilla luciferase activity. C/EBPb addition did not induce luciferase expression in Cebpb À/À MEF cells transfected with control, the À50 bp region or the À4 kb enhancer plasmids ( Figure 6B ). In contrast, constructs that contained the À850 kb site showed a C/EBPbdependent increase in luciferase activity. Of note, the À4 kb enhancer element in combination with the À850 bp site further increased expression, but also affected the background signal in the absence of exogenous C/EBPb, indicating C/EBPb-dependent and independent interaction of these two regulatory elements. Collectively, our data suggest a critical role of C/EBPb in the regulation of Nr4a1 expression during monocyte conversion. (Geissmann et al., 2003; Passlick et al., 1989) . Ly6C + monocytes are inflammatory cells with tissue infiltrating capacity, while Ly6C
C/EBPb Interacts with the Nr4a1 Promoter and Induces Its Expression
DISCUSSION
À cells seem to remain in the circulation and control vessel wall integrity (Auffray et al., 2007; Geissmann et al., 2003 (Gren et al., 2015; Schmidl et al., 2014; Zawada et al., 2011) Mechanistically, our findings suggest that C/EBPb binds to promoter and enhancer regions of Nr4a1 in monocyte-derived cells and activates Nr4a1 expression. Nr4a1 has been previously shown to be obligatory for Ly6C À monocyte development (Hanna et al., 2011) . Moreover, the same group showed recently that the second Nr4a1 enhancer (E2) was crucial for Ly6C À monocyte development in a Klf2-dependent manner (Thomas et al., 2016) . The authors subsequently focused on the control of Nr4a1 expression by the E2 fragment and reported that it was independent of C/EBPb, but under Klf2 control. We confirm these results, but show in addition that C/EBPb binds to both enhancers (E1, E2) and thereby regulates expression of Nr4a1. (Hanna et al., 2011) . Therefore it seems possible that both transcription factors are connected by a regulatory circuit. This is also supported by the fact that a small fraction of BM Ly6C À monocytes is still present in C/EBPb-deficient mice-a observation similar to Nr4a1 À/À animals (Carlin et al., 2013) . The phenotype of Nr4a1-deficient mice was attributed to a decreased survival of monocytes, accompanied by increased apoptosis in this cell lineage (Hanna et al., 2011) . Similarly, Cebpb À/À monocytes show increased apoptosis (Tamura et al., 2015) . However, C/EBPb-deficient Ly6C int monocytes lacked the Ly6C À monocyte gene signature, which was observed in C/EBPb-proficient Ly6C int cells, indicating a C/EBPb function beyond a mere survival phenotype. Collectively, our data indicate that Ly6C + monocytes represent an unstable cell population with a molecular and epigenetic default differentiation potential toward Ly6C À monocytes.
However, even though Ly6C + cells seem to represent an a priori developmental stage, they are equipped with unique functional properties such as tissue infiltration and pro-inflammatory activity , which cannot be acquired by Ly6C À monocytes (Varol et al., 2009 ). This raises the questions, whether the epigenetic landscape can change under inflammatory conditions to prevent the default differentiation into Ly6C À cells. It is possible that the observed shift in human monocyte composition under pathological conditions toward increased abundance of CD14 + CD16 + cells (reviewed in Wong et al., 2012) represents such a case. It will be critical to identify how plasticity is preserved in Ly6C + cells and how Ly6C + monocytes balance their developmental fate to either become circulating Ly6C À monocytes or to differentiate into monocyte-derived tissue macrophages.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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BULK RNA SEQUENCING
RNA-seq of populations was performed as described previously (Lavin et al., 2014) . In brief, 10 3 -10 5 cells from each population were sorted into 50 mL of lysis/binding buffer (Life Technologies) and stored at À80 C. mRNA was captured with Dynabeads oligo(dT) (Life Technologies) according to manufacturer's guidelines. We used a derivation of MARS-seq . Briefly, RNA was reversed transcripted with MARS-seq barcoded RT primer in a 10 mL volume with the Affinity Script kit (Agilent). Reverse transcription was analyzed by qRT-PCR and samples with a similar CT were pooled (up to 8 samples per pool). Each pool was treated with Exonuclease I (NEB) for 30 min 37 C and subsequently cleaned by 1.2X SPRI beads. Afterward, the cDNA was converted to double-stranded DNA with a second strand synthesis kit (NEB) in a 20 mL reaction, incubating for 2.5 hr at 16 C. The product was purified with 1.43 volumes of SPRI beads, eluted in 8 mL and in vitro transcribed (with the beads) at 37 C overnight for linear amplification using the T7 High Yield RNA polymerase IVT kit (NEB). Following IVT, the DNA template was removed with Turbo DNase I (Ambion) 15 min at 37 C and the amplified RNA (aRNA) purified with 1.23 volumes of SPRI beads. The aRNA was fragmented by incubating 2.5 min at 70 C in Zn2+ RNA fragmentation solution (Ambion) and purified with 2X SPRI beads. The aRNA (5 ml) was preincubated 3 min at 70 C with 1 mL of 100 mM MARS seq ligation adaptor; then, 14 mL of a mix containing 9.5% DMSO, 1 mM ATP, 20% PEG8000, and 1 U/ml T4 ligase (NEB) in 50 mM Tris HCl pH7.5, 10 mM MgCl2, and 1 mM DTT was added. The reaction was incubated at 22 C for 2 hr. After 1.5X SPRI cleanup, the ligated product was reverse transcribed using Affinity Script RT enzyme (Agilent; reaction mix contains Affinity Script RT buffer, 10 mM DTT, 4 mM dNTP, 2.5 U/ml RT enzyme) and a primer complementary to the ligated adaptor. The reaction was incubated for 2 min at 42 C, 45 min at 50 C, and 5 min at 85 C. The cDNA was purified with 1.5X volumes of SPRI beads. The library was completed and amplified through a nested PCR reaction with 0.5 mM of P5_Rd1 and P7_Rd2 primers and PCR ready mix (Kapa Biosystems). The amplified pooled library was purified with 0.7X volumes of SPRI beads to remove primer leftovers. Library concentration was measured with a Qubit fluorometer (Life Technologies) and mean molecule size was determined with a 2200 TapeStation instrument. RNA-Seq libraries were sequenced using Illumina NextSeq-500. Raw reads were mapped to the genome (NCBI37/mm9) using hisat (version 0.1.6). Only reads with unique mapping were considered for further analysis. Gene expression levels were calculated using the HOMER software package (analyzeRepeats.pl rna mm9 -d < tagDir > -count exons -condenseGenes -strand + -raw) (Heinz et al., 2010) . Normalization and differential expression analysis was done using the DESeq2 R-package. Differential expressed genes were selected using a 2-fold change cutoff between at least two populations and adjusted p value for multiple gene testing > 0.05. Gene expression matrix was clustered using k-means algorithm (MATLAB function kmeans) with correlation as the distance metric. The value of k was chosen by assessing the average silhouette (MATLAB function silhouette) (3) for a range of possible values (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) .
INDEXING-FIRST CHROMATIN IP SEQUENCING
10
5 crosslinked cells were used for iChIP-seq, as described (Lara-Astiaso et al., 2014) . Briefly, following crosslinking for 8 min in 1% formaldehyde and quenched for 5 min in 0.125 M glycine, cells were FACS sorted, diluted in harvesting buffer (12 mM Tris-HCl, 0.1X PBS, 6 mM EDTA, 1.2X Protease Inhibitor [Roche]), pelleted by two rounds of centrifugation (15 min, 3,000 g, low acceleration and brake) and frozen at À80 C. Cell aliquots (around 10 ml) are thawed on ice and 2 mL of 3% SDS is added to achieve a concentration of 0.5% SDS. Chromatin was fragmented by sonication at high intensity and cycles of 30'' ON/30'' OFF with the NGS Bioruptor Sonicator (Diagenode) for 40 min. Cells were diluted 1:5 with sonication equilibration buffer (10 mM Tris-HCl, 140 mM NaCl, 0.1% sodium deoxycholate, 1% Tx-100, 1mM EDTA, 1X Protease Inhibitor) and sheared chromatin was immobilized on 15 mL Dynabeads Protein G (ThermoFisher) with 1.3 mg of anti-H3 antibody (ab1791, Abcam) for 20 hr on 4 C. The H3-bound beads were magnetized and washed 3 times with 150 mL 10mM Tris-HCl, 1X Protease Inhibitors and resuspended in 20 mL of the same buffer. Chromatin End Repair was performed by adding 30 mL of a master mix: 25 mL 2X ER mix (50 mM Tris-HCl ph 7.5, 20 mM MgCl2, 20mM DTT, 2mM ATP, 1mM dNTPs), 2 mL T4 PNK enzyme (10 U/ml NEB), and 2 mL T4 polymerase (3 U/ml NEB) to each sample and incubated at 12 C for 25min, 25 C for 25 min, and finally cooled to 4 C. After end repair, bead bound chromatin was washed once with 150 mL of 10mM Tris-HCl + Protease Inhibitors and re-suspended in 40 mL of the same buffer. Chromatin was A-tailed by adding 20 mL master mix (17 mL A-base add mix, 3 mL Klenow (3 0 ->5 0 exonuclease, 3 U/ml, NEB) to each well and incubated at 37 C for 30 min. Afterward, bead bound chromatin was washed once with 150 mL of 10 mM Tris-HCl + Protease Inhibitors and resuspended in 19 mL of the same buffer. Chromatin was indexed by adding 5 mL of 0.75 mM Y-shapped Indexed Adaptors (containing P5 and P7 sequences) to each well which were ligated to the chromatin's DNA ends by adding 34 mL of AL master mix (29 mL 23 Quick Ligation Buffer and 5 mL Quick DNA ligase [NEB] ) to each well. Samples were mixed and incubated at 25 C for 40min in a thermal cycler. Bead bound indexed chromatin was washed once as described above in order to remove non-ligated adaptors. After wash, samples were removed from the magnet, beads were re-suspended in 12.5 mL of 100 mM DTT and incubated for 5 min at room temperature. Then, 12.5 mL of 2X chromatin release buffer (500 mM NaCl, 2% SDS, 2% Sodium Deoxycholate, 2X protease Inhibitors) was added, samples were mixed and incubated at 37 C for 30 min. After the release incubation, magnetic beads were again thoroughly re-suspended and pooled together in groups of <10 samples resulting in a pool volume of 200-250 ml. The pooled indexed chromatin samples were concentrated using a 50 Kda cutoff Centricon (Amicon). Target antibody was added and incubated at 4 C for 3 hr, then 50 mL with Protein G Magentic beads were added and IP was incubated for 1 more hour. For each ChIP, we used 1.5 mg of anti-H3K4me1 (ab8895; Abcam) and 2.5 mg of anti-H3K4me2 (ab32356; Abcam), anti-H3K4me3 (07-473; Millipore) and anti-H3K27ac (ab4729; Abcam). After incubation, ChIP Buffer was removed and samples were washed 5 times with cold RIPA (200 ml per wash), twice with RIPA buffer supplemented with 500 mM NaCl (200 ml per wash), twice with LiCl buffer (10 mM TE, 250mM LiCl, 0.5% NP-40, 0.5% DOC), once with TE (10 Mm Tris-HCl pH 8.0, 1 mM EDTA), and then eluted in 50 mL of 0.5% SDS, 300 mM NaCl, 5 mM EDTA, 10 mM Tris-HCl pH 8.0. The eluate was treated sequentially with 2 mL of RNaseA (Roche, 11119915001) for 30 min at 37 C, 2.5 mL of Proteinase K (NEB, P8102) for additional 2 hr at 37 C and 8 hr at 65 C to revert formaldehyde crosslinking. DNA was purified with SPRI beads (90 ml, Agencourt AMPure XP beads, Beckman Coulter) according to manufacturer's protocol. The DNA was eluted in 23 mL EB buffer (10 mM Tris-HCl, pH 8.0) by pipette mixing 25 times. The library was completed and amplified through a PCR reaction with 0.5 mM of PCR forward and PCR reverse primers and PCR ready mix (Kapa Biosystems). Following the amplification step, DNA concentration was measured, and equivalent amounts of barcoded ChIPed DNA from each sample were pooled together. After barcoding, pooled DNA was sequenced (HiSeq 1500, Illumina) to achieve a minimum of 10 7 aligned reads per sample.
ATAC SEQUENCING
20,000 cells were used for ATAC-seq (Buenrostro et al., 2013) applying described changes (Lara-Astiaso et al., 2014) . Briefly, nuclei were obtained by lysing the cells with cold lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM MgCl 2 , 0.1% Igepal CA-630) and nuclei were pelleted by centrifugation for 30 min at 500 g, 4 C using a swing rotor with low acceleration and brake settings. Supernatant was discarded and nuclei were re-suspended in 25 mL reaction buffer containing 2 mL of Tn5 transposase and 12.5 mL of TD buffer (Nextera Sample preparation kit from Illumina). The reaction was incubated at 37 C for 1 hr. DNA was released from chromatin by adding 5 mL of clean up buffer (900 mM NaCl, 300 mM EDTA), 2 mL of 5% SDS, and 2 mL of Proteinase K (NEB) followed by an incubation for 30 min at 40 C. Tagmentated DNA was isolated using 23 SPRI beads and eluted in 21 ml. For library amplification, two sequential 9-cycle PCR were performed in order to enrich small tagmentated DNA fragments. We used 2 mL of indexing primers included in the Nextera Index kit and KAPA HiFi HotStart ready mix. After the first PCR, the libraries were selected for small fragments (less than 600 bp; 0.65X) using SPRI cleanup. Then a second PCR was performed with the same conditions in order to obtain the final library. DNA concentration was measured with a Qubit fluorometer (Life Technologies) and library sizes were determined using TapeStation (Agilent Technologies). Libraries where sequenced on a Hiseq 1500 for an average of 20 million reads per sample.
PROCESSING OF CHIP-SEQ AND ATAC-SEQ
Reads were aligned to the mouse reference genome (mm9, NCBI 37) using Bowtie2 aligner version 2.2.5 (Langmead et al., 2009) with default parameters. The Picard tool MarkDuplicates from the Broad Institute (http://broadinstitute.github.io/picard/) was used to remove PCR duplicates. To identify regions of enrichment (peaks) from ChIP-seq (H3K4me1, H3K4me2, H3K4me3, and H3K27ac), we used the HOMER package makeTagDirectory followed by findPeaks command ''-style histone.'' For ATACseq we used makeTagDirectory followed by findPeaks command ''-style factor -size 300,'' respectively (Heinz et al., 2010) . Union peaks file were generated for each of H3K4me1, H3K4me2, H3K4me3, and H3K27ac by combining and merging overlapping peaks in all samples.
CHROMATIN AND MOTIF ANALYSIS
All ChIP-seq peaks were binned to 1 kb size. To create the table of samples, we used annotatePeaks.pl from HOMER package passing the binned peak file and option ''-raw'' and normalized to an equal number of reads in merged peaks. We consider promoters to be peak center <1 kb from TSS of nearest gene. H3K4me3 regions used are only near promotor areas, while binned the peaks of H3K4me1, H3K4me2, and H3K27ac used are all non-promotor areas. Noise was set at $80% of all normalized value. The region intensity was given in log-base2 of the normalized density (log2(x+1)). Fold change bins were considered changing when delta between samples (log2(x+noise)) was > 1 (red line in Figure 4A ). Kmeans clustering was performed using MATLAB function kmeans with the distance metric set to ''correlation.'' Motif Analysis was performed inside ATAC peaks and differential regions were used as input for the HOMER package motif finder algorithm findMotifGenome.pl (Heinz et al., 2010) .
SINGLE CELL SEQUENCING
MARS-seq reads were processed as previously described (Paul et al., 2015) . Briefly, mRNA from cells sorted into MARS-seq capture plates was barcoded and converted into cDNA and pooled using an automated pipeline. The pooled sample was then linearly amplified by T7 in-vitro transcription and the resulting RNA was fragmented and converted into a sequencing-ready library by tagging the samples with pool barcodes and Illumina adaptor sequences during ligation, followed by reverse transcription and PCR. Each pool of cells was tested for library quality and concentration as described earlier . All RNA-seq libraries (pooled at equimolar concentration) were sequenced using an Illumina NextSeq 500. Mapping of reads was done using hisat (version 0.1.6) to mm9 genome. Reads with multiple mapping positions were excluded. Reads were associated with genes, if they were mapped to an exon defined by a reference set obtained from Gencode. Exons of different genes that share genomic position on the same strand were considered as a single gene with concatenated gene symbol. Cells with less than 200 UMIs were discarded from the analysis. Genes with mean expression smaller than 0.005 UMIs/ cell or with above average expression and low coefficient of variance (<1.2) were also discarded. In order to assess the heterogeneity of blood monocyte subtypes, we used a recently published multinomial mixture-model algorithm (Paul et al., 2015) (http://compgenomics.weizmann.ac.il/tanay/?page_id=649). A brief summary of the algorithm is described below and its detailed description can be found in our earlier publication (Paul et al., 2015) . Low-level processing of MARS-Seq reads results in a matrix U with n rows and m columns, where rows represent genes and columns represent cells. Entry Uij contains the number of unique molecular identifiers (UMIs) from gene i that were found in cell j. The model assumes that each cell belongs to one of K cell types and that each cell type defines a different distribution of transcripts within cells.
Our model assumes that cells are sampled uniformly from the population, and that each cell type dictates a multinomial distribution over the sample of sequenced RNA molecules. The model consists of three types of parameters: map j -The assignment of cell j to one of K cell types. a i;map j -the probability of observing gene i in cell j, assuming that j belongs to cell type map j . b ib j -a positive inflation factor accounting for batch effect on the expression of gene i (b j is the batch of cell j).
A pseudo EM algorithm was used to infer the assignment of cells to types, gene probability within cell type, and magnitude of batch effect. The algorithm outline is as follows:
Statistical significance was defined as p < 0.05. Sample sizes were chosen according to standard guidelines. Number of animals is indicate as ''n.'' Of note, sizes of the tested animal groups were also dictated by availability of the transgenic strains and litter sizes, allowing littermate controls. Pre-established exclusion criteria are based on IACUC guidelines. As for in vitro experiments, samples were excluded from analysis only in case of clear technical problems. Animals of the same age, sex, and genetic background were randomly assigned to treatment groups. The investigator was not blinded to the mouse group allocation. Tested samples were blindly assayed.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the RNA-, ChIP-, and ATAC-seq datasets reported in this paper can be found at GEO: GSE95702.
